Market News
Market news
-
News AmpliPhi granted Japanese patent covering the use of phage therapy to resensitize Pseudomonas aeruginosa infections to antibiotics
AB-PA01 designed to broadly target both CF and non-CF Pseudomonas isolates and potentially eradicate the infection instead of merely keeping it at bay. -
News Vaxil announces key US Patent and Trademark Office Notice of Allowance for its immunotherapy
First US Patent issued to Vaxil since the company began developing its immunotherapies 10 years ago. -
News Astellas transfers US manufacturing subsidiary to Avara
Subsidiary will be renamed Avara Pharmaceutical Technologies. -
News Newer therapies will steer type 2 diabetes market in South-East Asia to $2.7 billion by 2022
Increase will be driven by the growing use of recently approved and emerging branded T2DM therapeutics, in favour of lower-cost generic products, says GBI Research. -
News Allergan announces sale of Anda distribution business to Teva Pharmaceuticals
Continues Allergan's evolution into focused brand growth pharma leader. -
News Regeneron and Adicet Bio collaborate to discover and develop next-generation engineered immune cell therapeutics
Companies to pursue "off-the-shelf" cellular therapies in oncology. -
News Allergan completes divestiture of global generics business to Teva
Sale advances company's evolution into a focused branded growth pharma leader. -
News Pfizer aims to become industry leader in gene therapy with acquisition of Bamboo Therapeutics
Acquisition combines Bamboo’s gene therapy portfolio, advanced vector design, and production technologies and capabilities with Pfizer’s global scale, research, development and commercialization experience. -
News Rare cancer drug which significantly delays progression of advanced thyroid cancer is left off relaunched Cancer Drugs Fund
People with radioiodine refractory differentiated thyroid cancer are overlooked as Lenvima is not scheduled for evaluation by NICE or the new Cancer Drugs Fund. -
News Venous thromboembolism therapeutics market set to hit $3.7 billion by 2025
Steady growth will be driven by the uptake of novel oral anticoagulants, which represent important advances over warfarin, a cheap and established anticoagulant, says GlobalData. -
News Merck to provide Provantage End-to-End development and manufacturing services to Y-mAbs for lead antibody compound
Includes scale-up and GMP manufacturing of drugs in late-stage development. -
News Tokai Pharmaceuticals announces reduction in force
Reduction is designed to reduce operating expenses while the company conducts a comprehensive evaluation of strategic options for galeterone and its pipeline. -
News Sunovion submits NDA for SUN-101/eFlow to FDA for the treatment of patients with COPD
If approved, SUN-101/eFlow will be the first nebulized long-acting muscarinic antagonist (LAMA) for the long-term, maintenance treatment of airflow obstruction in patients with COPD. -
News Slovakia-based CDMO sells registration dossiers for more than 20 pharma products
The portfolio of products will be marketed by Xantis Pharma throughout Central and Eastern Europe. -
News Sanofi receives FDA approval of Adlyxin for treatment of adults with type 2 diabetes
Adlyxin is approved as Lyxumia in more than 60 countries. -
News Codexis completes obligations under R&D agreement with leading biopharmaceutical company
Enzyme developed with CodeEvolver technology for preclinical therapeutics program exceeds agreement requirements. -
News Vectura initiates legal proceedings against GSK
GSK accused of patent infringement. -
News Cytokinetics and Astellas announce option right for tirasemtiv and expansion of global collaboration for CK-2127107 in ALS
Cytokinetics to receive $65 million in upfront payments and $30 million in additional sponsored R&D; potential for more than $100 million in payments associated with the exercise of the option. -
News NeuroDerm issued a new US patent for aqueous apomorphine covering concentrated subcutaneously delivered pharmaceutical compositions
Company's ND0701 formulation intended for chronic therapy of Parkinson's disease and is developed for continuous subcutaneous administration by a small, low-volume, disposable patch-pump. -
News GSK announces significant new investment in UK manufacturing network
Investment in advanced manufacturing of new respiratory and biopharmaceuticals portfolio. -
News John C. Lechleiter to retire as Lilly CEO; Board elects David A. Ricks as successor
Ricks will assume President and CEO roles on 1 January 2017, and become chairman of Lilly's board on 1 June 2017. -
News Top 3 therapy areas account for 68% of overall pharmaceutical industry pipeline
Oncology, infectious diseases and central nervous system disorders accounted for a combined 68% of the overall pharmaceutical industry pipeline as of Q1 2016, says GBI Research. -
News Ocular Therapeutix receives CRL from FDA for its NDA for Dextenza
FDA reports deficiencies in manufacturing process and controls identified during a pre-NDA approval inspection of the Ocular Therapeutix manufacturing facility. -
News Innova Biosciences introduces InnovaCoat GOLD-Carboxyl nanoparticles
Functionalized gold nanoparticles for easy, fast covalent conjugation of antibodies. -
News Shire launches pediatric indication for immunodeficiency treatment HyQvia in Europe
HyQvia is the only subcutaneous IG treatment for primary and certain secondary immunodeficiencies that can be administered in one site, once a month. -
News N-of-One Secures $7 Million in Series B financing
The financing will be used to expand the company's leading precision medicine decision support solutions in oncology. -
News RedHill Biopharma receives additional US patent covering RHB-105 ahead of confirmatory Phase III study for H. pylori infection
Company has received a Notice of Allowance for an additional U.S. patent covering RHB-105, expected to be valid until 2034 once granted. -
News BMS announces availability of FDA-approved Orencia ClickJect
New Orencia ClickJect Autoinjector offers accurate dose self-injection with push button operation, and confirmation that the full dose has been injected. -
News Despite 330 pipeline products, stem cell therapies face commercial challenges
The stem cells field is still surrounded by a wide variety of obstacles, most notably the high cost of research, according to key opinion leaders. -
News Recipharm appoints new General Manager in Research Triangle Park
Ann Flodin will be responsible for managing daily operations in Recipharm in Research Triangle Park and will focus on expanding and strengthening the development services Recipharm offers its customers in the US. -
News Lonza reports best first half in history with continued strong momentum
Pharma&Biotech’s outstanding operational performance across all assets bolstered the strong half-year results. -
News Study finds 88% of pharma companies base global launch planning on regulatory affairs guidance
Various tools help drug companies establish successful global launch plans. -
News Responding to customer needs with ergonomic design
Enhancements to Thermo Scientific Finnpipette F1 and F1-ClipTip pipetting systems improve comfort. -
News Pfizer Receives WHO prequalification for multi-dose vial presentation of Prevenar 13
Designation will enable increased access to vaccine in world’s poorest countries. -
News Vietnamese pharmaceutical market to reach $6.6 billion by 2020
While the Vietnamese market is seen as attractive for pharmaceutical companies, drug prices are high compared with average incomes, says GlobalData. -
News FDA expands indication for type 2 diabetes treatment Synjardy
Expanded indication now includes treatment-naïve adults. -
News Dr Reddy's launches Omeprazole and sodium bicarbonate capsules in the US market
Product is a generic version of Zegerid - an acid reflux treatment. -
News Teewinot Life Sciences secures first US patent covering an apparatus for the biosynthetic production of authentic THCA, CBDA And CBCA cannabinoids
The apparatus facilitates the manufacture of authentic cannabinoids that are purer in form and more cost effectively produced than what is currently available in the marketplace. -
News Merck relaunches customer collaboration centers with new concept and M Lab name
Enables explorations of new technologies and solutions to address development and manufacturing challenges. -
News Advanced Proteome Therapeutics formulates strategic plan featuring novel antibody program
The company is focusing on enabling technology, designed to link antibodies to drugs or toxins to produce pure and homogeneous ADCs. -
News Vetter plans to invest $320 million on 10-year expansion plan
Company provides insights into its long-term expansion plans that include the purchasing of property in the City of Des Plaines -
News Sartorius acquires ViroCyt
Acquisition expands bioanalytical portfolio of Lab Products & Services division. -
News MRC Technology monetises royalties on cancer drug Keytruda to expand medical research activities
The charity will now also be able to pursue exciting novel research and development collaborations with new partners. -
News Amgen and Daiichi Sankyo announce agreement to commercialize biosimilars in Japan
The deal includes several biosimilars in late-stage development, including biosimilars of adalimumab, bevacizumab and trastuzumab. -
News Saudi Arabia’s pharmaceutical market set to hit $6 billion by 2020 as nation’s wealth increases
This impressive expansion can be attributed to a growing population, rising wealth levels, and demand for patented pharmaceutical products, says GlobalData. -
News Avacta and Glythera collaborate to develop novel, potentially highly potent, drug class
The collaboration will evaluate the use of Avacta’s Affimer technology in combination with Glythera’s PermaLink conjugation chemistry. -
News Apax Partners to acquire the operating subsidiaries of Invent Farma
Invent Farma develops, manufactures and markets generic drugs. -
News Brexit uncertainty favours internationally focused pharmaceutical professionals
Its likely that a number of firms will relocate their services to mainland Europe or Ireland. -
News BioStem Technologies begins construction of new laboratory facility
New facility will house multiple general labs, cleanrooms, and small batch manufacturing rooms. -
News Cambrex completes $50 million investment in large-scale API manufacturing and storage
The company's investment reflects the strong market demand for small molecule APIs. -
News Emulate to collaborate with Seres Therapeutics to support the development of novel microbiome therapeutics
Seres to use Emulate's Intestine-Chip technology to identify promising new microbiome therapeutic candidates for inflammatory bowel disease. -
News SGS introduces fast, accurate genotypic microorganism identification offering at its Chicago, IL facility
FDA guidance states that genotypic methods have been demonstrated to be more accurate and precise than traditional biochemical and phenotypic methods. -
News Cipla to launch South Africa’s first biotech manufacturing facility
The plant will manufacture biosimilars and construction is scheduled to start in early 2017, with full operations expected to commence in the third quarter of 2018. -
News Scots first to receive breakthrough immunotherapy for lung cancer
Eligible patients in Scotland will be the first in the UK to access this life-extending treatment and will be ahead of those patients in England and Wales. -
News Powerful software utility for modelling freeze drying cycles
SP Scientific's LyoModelling Calculator enables those developing freeze drying cycles to calculate the time required for primary drying and the maximum product temperature. -
News FDA approves first and only single monthly injection for a PCSK9 inhibitor
Amgen's Repatha (evolocumab) Pushtronex system (on-body infusor with prefilled cartridge) provides a new, monthly single-dose administration option. -
News Global API market revenues to reach $143 billion in 2016
According to a New Market Report Published by Persistence Market Research, the Global API market is estimated to reach $186 billion by 2020, with North America accounting for 35% revenue shares.. -
News New cell culture plate eliminates edge effect during extended incubation
Thermo Scientific Nunc Edge 2.0 plate is designed to cost effectively increase cell consistency and productivity in cell-based assays. -
News CPHI Korea sees 25% growth as domestic pharma economy forecast to become 7th globally by 2020
Government initiatives driving biosimilars and health foods sectors, with increased international partnerships. -
News Claristep filtration system: fast, easy and reliable sample preparation
Fast small-volume clarification that does not add leachables or extractables to the original sample. -
News Shire receives extension of Market Authorization in Europe for Revestive
First therapy indicated in the EU for use in patients aged one year and above with Short Bowel Syndrome, a rare gastrointestinal condition. -
News Major players in type 2 diabetes shifting focus to pricing to maintain market share
With cost pressures burdening many health systems, competitive pricing is a strategy that other companies are likely to adopt with me-too drugs in late-stage development, says GlobalData. -
News Sanofi enters into confidentiality agreement with Medivation
Sanofi agrees to standstill and to withdraw consent solicitation. -
News Sartorius Stedim BioOutsource introduces new Released N-Glycan Assay
In-depth profiling of IgG glycosylation coupled with ADCC assays enables generation of robust biosimilar comparability data. -
News Sartorius Stedim Biotech acquires US start-up kSep Systems
Transaction to expand SSB’s bioprocessing product portfolio with innovative single-use centrifuges. -
News NICE blocks immunotherapy drug nivolumab (Opdivo) for kidney cancer
Decision comes despite nivolumab being accepted for the Early Access to Medicines Scheme (EAMS) based upon some impressive Phase III clinical trial results. -
News RedHill Biopharma and IntelGenx announce definitive agreement for commercialization of Rizaport for migraines with Grupo JUSTE in Spain
Rizaport was recently approved for marketing in Germany under the European Decentralized Procedure; RedHill and IntelGenx continue to work together to secure additional commercialization partners for Rizaport in the US, Europe and other territories. -
News Transdermal Delivery Solutions and MHC Medical Products announce license for Penetran+Plus topical pain reliever
With the acquisition of Penetran-Plus, MHC expands into the OTC pain relief market. -
News Recipharm increases blow fill seal capacity in Kaysersberg, France
The investment will bring the total number of lines to eight, to meet the growing demand of the service. -
News BMS acquires Cormorant Pharmaceuticals
Gains full-rights to Cormorant’s HuMax-IL8 antibody program and lead asset HuMax-IL8 in Phase I/II development. -
News SP Scientific details expanded capabilities in pharmaceutical processing
Company now able to offer a one-source solution for a complete range of pharmaceutical processing equipment. -
News Novo Nordisk invests DKK 400 million in an expanded production plant in Kalundborg
New facilities will provide greater flexibility. -
News Zenith Technologies appoints serialization director
The appointment comes as the pharmaceutical industry faces the challenge of complying with new legal requirements for the authentication and barcoding of licensed drug products. -
News Lyon manufacturing facility returns to the Vectura Group
The facility currently manufactures seven oral products for the Group's partners. -
News Merck and Moderna collaborate to advance novel mRNA-based personalised cancer vaccines with Keytruda
Collaboration combines Merck’s leadership in immuno-oncology with Moderna’s pioneering mRNA vaccine technology and rapid cycle time, small-batch GMP manufacturing capabilities. -
News Rx-360 summary of the WHO Draft Guidelines on Qualification and Validation
In addition to the main guidelines, appendices on validation and qualification are included. -
News Arena Pharmaceuticals announces shift to focus on proprietary clinical stage pipeline
Additional cost reductions implemented to support development program prioritisation. -
News China forecasted as the fastest growing biologics market over the next decade with Chinese NCEs within 5 years
International-domestic pharma partnerships to drive next wave of growth, alongside emerging Chinese multinational CMOs. -
News LEO Pharma enters biologics through strategic partnership with AstraZeneca
The partnership covers potential new medicines for atopic dermatitis and psoriasis. -
News Catalent agrees to commercially supply Palatin Technologies' new bremelanotide pen injector product
Bremelanotide is designed to treat hypoactive sexual desire disorder, the most common form of FSD, in premenopausal women. -
News Chinese authorities issue operating approval to Siegfried Nantong
This significant site addition to Siegfried’s production network strengthens the company’s long-term competitiveness. -
News Torrent Pharma acquires manufacturing unit of Hyderabad-based Glochem Industries
With this acquisition, the company will have three API facilities for the regulated markets. -
News GSK's MenABCWY vaccine set to revolutionize meningococcal disease prevention market
Should the MenABCWY vaccine perform well in upcoming Phase III studies, it has the potential to become market leader, says GlobalData. -
News Innovative first-in-class products comprise 30% of diabetes complications pipeline
New targets need to be identified and converted into improved therapeutic options, particularly in order to develop therapies more aligned with the underlying disease pathophysiology, says GBI Research. -
News Sartorius acquires cell screening specialist IntelliCyt
Unique technology for cell analysis in Biopharma applications. -
News Merck partners with South Korean Institute to enhance vaccine production
Collaboration will improve manufacturing processes to deliver greater yield, allowing higher recovery and providing higher purity vaccines. -
News Novartis adds bispecific antibodies to its growing immuno-oncology portfolio through collaboration and licensing agreement with Xencor
Agreement is the latest in a series of acquisitions and strategic collaborations that have bolstered Novartis' deep and diverse immuno-oncology pipeline. -
News Pfizer invests in a new world-class global biotechnology center in China
State-of-the-art facility will foster the continued development of the biotechnology industry in China, further supporting national healthcare reforms. -
News Catalent launches FastChain service
New service meets the increasing demand for speed and flexibility in global clinical trials. -
News Merck’s acquisition of Afferent Pharmaceuticals provides platform into IPF market
The deal will mean Merck acquires Afferent’s lead candidate, AF-219, which is currently in Phase II trials in IPF patients with persistent cough, says GlobalData. -
News Sanner launches senior-friendly closure for effervescent packaging
The new FOG 27 closure can be opened in about a third of the time — and with 70% less physical effort compared with conventional closures. -
News Sandoz announces plans for five major global biosimilar launches by 2020
Investments of more than USD 1 billion in state of-the-art biomanufacturing facilities, backed by industry-leading capabilities as part of Novartis, positions Sandoz to deliver biosimilars at unprecedented scale. -
News Mylan launches generic Avodart Capsules
Product is indicated as monotherapy for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve symptoms, reduce the risk of acute urinary retention and reduce the risk of the need for BPH-related sur... -
News Cobra Biologics and Alligator Bioscience extend drug development partnership
Project will deliver second cell line for manufacture of immuno-oncology antibody ADC-1015 following ADC-1013 success. -
News Nacimbio launches complex programme for antiretroviral drugs production
Cipla agrees to transfer API manufacturing technology reqired for HIV and Hepatitis C drugs. -
News Novartis' Entresto could prevent or postpone over 28,000 US deaths per year among HFrEF patients
A new analysis published in JAMA Cardiology is the first to quantify the possible impact of Entresto's potential benefit in reducing death. -
News Specialty pharmaceuticals: to compare cost with value, more productivity research is key
A new commentary published in The American Journal of Pharmacy Benefits argues that the value of specialty pharmaceuticals — to patients, employers and society at large — has been left out of the discussion. -
News Tablet press investment at Juniper Pharma Services
Latest addition to the company's suite of tablet manufacturing equipment enables the CDMO to produce single and bi-layer tablets in multiple tooling formats. -
News Recipharm announces global serialisation collaboration
The CDMO has formed a global partnership with Marchesini, SEA Vision and TraceLink to introduce new serialisation capabilities. -
News OPKO’S Rayaldee product receives FDA approval
First drug to use Catalent’s proprietary OptiShell capsule technology to achieve extended release profile. -
News Leukemia has largest pipeline and most first-in-class innovation in hematological cancers space
Of the three major indications within hematological cancer, namely leukemia, lymphoma and myeloma, leukemia has the largest pipeline, with 798 products in active development. -
News CPHI Pharma Awards 2016 opens with four extra categories
Entry submission is now open: the awards bestow recognition on the industry’s most outstanding achievements. -
News Murdo Gordon appointed Executive Vice President and Chief Commercial Officer, BMS
He will lead the company's Worldwide Markets in addition to a new Worldwide Commercialization team. -
News Impax signs definitive agreements to acquire generic products
The agreements include the return to Impax of its rights to its pending abbreviated new drug application for the generic equivalent to Concerta (methylphenidate hydrochloride). -
News Idiopathic pulmonary fibrosis market will grow from $907 million in 2015 to $3.2 billion by 2025
Growth will primarily be driven by increased use of expensive therapies, a rise in diagnosed prevalent cases of IPF, and the launch of two novel therapies, says GlobalData. -
News Kite Pharma opens state-of-the-art T-cell therapy manufacturing facility
43,500-sq-ft plant next to Los Angeles International Airport will support production of engineered CAR and TCR cancer immunotherapies. -
News SGS introduces new comprehensive drug compatibility study testing at expanded Shanghai facility
New service offers analysis of potential extractable and leachable contamination within pharmaceutical products. -
News PaizaBio: China approves Drug Marketing Authorization Holder pilot plan
Move approves the use of contract manufacturing organisations. -
News Famar to acquire Roche's Leganes site
Site provides Famar with capacities and expertise in the production of solid dosage forms with high-potency APIs, which represents new technology for the company. -
News ARIAD completes strategic review and announces plans for growth
Key outcome of the strategic review is a commitment to commercializing brigatinib in the US, subject to approval by the FDA. -
News Pharmaceutical industry licensing deals soared to record $46.2 billion in 2015
Pharmaceutical licensing deal values increased by 37.1% year-to-year, from $33.7 billion in 2014 to $46.2 billion in 2015, driven primarily by Sanofi. -
News Breakthrough combination for patients with skin cancer receives fast-tracked ‘yes’ from NICE
This represents one of the fastest ever approvals by NICE – UK patients will be the first to benefit across Europe. -
News NICE denies NHS patients access to Vertex's Orkambi
“As a result of applying the wrong appraisal process, approximately 2,700 people in England who could benefit from Orkambi are being forced to continue waiting for access.” -
News Zika vaccine race overlooks need for global strategy to combat mosquito-borne diseases
Vast majority of Zika vaccine products are currently in early preclinical trials, indicating that it will take many years until one of them receives market approval, says GlobalData. -
News Forte Pharma, Reig Jofre’s nutritional supplements line, enters in Hong Kong and Macao
This operation is part of Reig Jofre's internationalization plan, by which 60% of company sales are now made outside Spain, with a target of 70% in 2019. -
News Bavarian Nordic announces expansion of Imvamune orders from Canadian government
PHAC orders a total of 360,000 doses of the smallpox vaccine. -
News Hovione announces the groundbreaking expansion plans of its New Jersey Facility
Expansion will introduce a new commercial spray dryer unit to complement the existing pilot unit and this installation will be specifically designed to handle potent APIs -
News 80% of pharma companies have new product planning groups on brand commercialization committees during early-stage development
Internal functions are key for companies' committees across stages of development. -
News Sartorius Stedim Biotech launches innovative ambr 250 modular bioreactor system
New expandable benchtop workstation with unique single-use bioreactor design offers a simple approach to process development for fermentation and cell culture.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance